Glaxo SmithKline U.S. Management Will Be Early Test Of Integration Process
Executive Summary
Glaxo SmithKline's U.S. management team is to be worked out during the merger integration process between the two companies.
You may also be interested in...
Glaxo SmithKline
Merged company will not create new global headquarters in the New York/New Jersey region as previously announced (1"The Pink Sheet" Jan. 24, p. 18). U.S. operations will instead be based out of existing companies' headquarters in Research Triangle Park, N.C. (Glaxo Wellcome) and Philadelphia (SmithKline Beecham). Sales and marketing components in the U.S. will also remain separate during the first phases of the merger process (2"The Pink Sheet" Feb. 7, p. 19)
Glaxo SmithKline
Merged company will not create new global headquarters in the New York/New Jersey region as previously announced (1"The Pink Sheet" Jan. 24, p. 18). U.S. operations will instead be based out of existing companies' headquarters in Research Triangle Park, N.C. (Glaxo Wellcome) and Philadelphia (SmithKline Beecham). Sales and marketing components in the U.S. will also remain separate during the first phases of the merger process (2"The Pink Sheet" Feb. 7, p. 19)
Glaxo SmithKline Taking Soft Merger Route: Will Start With Two U.S. Heads
The U.S. pharmaceutical operations of Glaxo Wellcome and SmithKline Beecham will not be combined immediately as part of the merger integration process.